Gunjan Y. Gandhi M.B.B.S. (M.D.), M.S.

Associate Professor & Program Director, Endocrinology Fellowship

Department: Department of Medicine

Business Phone: (904) 244-8846

Business Email: Gunjan.gandhi@jax.ufl.edu

Appointments and Locations

Board Certifications

Internal Medicine
Endocrinology, Diabetes and Metabolism

Clinical Profile

Specialties

Endocrinology, Diabetes and Metabolism

Publications

2022

Clinical Considerations for Insulin Therapy in Older Adults with Type 1 Diabetes.

Drugs & aging.39(1):23-37[DOI] 10.1007/s40266-021-00900-3.[PMID] 34664212.

2 citations·PubMed·Publisher's Site

2022

Management of Hyperglycemia in Older Adults with Type 2 Diabetes.

Drugs & aging.39(1):39-58[DOI] 10.1007/s40266-021-00910-1.[PMID] 34921341.

2 citations·PubMed·Publisher's Site

2021

Acute Unilateral Nonhemorrhagic Adrenal Infarction in Pregnancy.

AACE clinical case reports.7(3):228-229[DOI] 10.1016/j.aace.2020.12.015.[PMID] 34095495.

PubMed·Publisher's Site

2021

Clavicular Metastasis as an Initial Presentation of Papillary Thyroid Cancer.

Case reports in endocrinology.2021():6662071-[DOI] 10.1155/2021/6662071.[PMID] 34484842.

1 citations·PubMed·Publisher's Site

2021

In type 2 diabetes, tirzepatide reduced HbA1c vs. semaglutide.

Annals of internal medicine.174(11):JC127-[DOI] 10.7326/ACPJ202111160-127.[PMID] 34724396.

PubMed·Publisher's Site

2020

In type 2 diabetes, some glucose-lowering drugs reduce HbA1c more than others; drugs do not differ for mortality.

Annals of internal medicine.173(10):JC53-[DOI] 10.7326/ACPJ202011170-053.[PMID] 33197350.

PubMed·Publisher's Site

2020

Symptomatic Pituitary Metastasis as Initial Manifestation of Renal Cell Carcinoma: Case Report and Review of Literature.

Case reports in endocrinology.2020():8883864-[DOI] 10.1155/2020/8883864.[PMID] 32908722.

1 citations·PubMed·Publisher's Site

2016

In type 2 diabetes treated with high-dose insulin, liraglutide reduced HBA1c.

Annals of internal medicine.165(8):JC40-[DOI] 10.7326/ACPJC-2016-165-8-040.[PMID] 27750300.

PubMed·Publisher's Site

2015

ACP Journal Club. Review: In patients with type 2 diabetes who fast, sitagliptin reduces hypoglycemia more than sulfonylurea.

Annals of internal medicine.163(8):JC8-[DOI] 10.7326/ACPJC-2015-163-8-008.[PMID] 26502145.

PubMed·Publisher's Site

2014

ACP Journal Club. Review: sodium-glucose cotransporter 2 inhibitors reduce HbA1c and weight but increase infections.

Annals of internal medicine.160(2):JC10-[DOI] 10.7326/0003-4819-160-2-201401210-02010.[PMID] 24445708.

1 citations·PubMed·Publisher's Site

2012

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

Systematic reviews.1():33-[DOI] 10.1186/2046-4053-1-33.[PMID] 22828169.

58 citations·PubMed·Publisher's Site

2012

Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report.

Case reports in endocrinology.2012():185454-[DOI] 10.1155/2012/185454.[PMID] 23346426.

14 citations·PubMed·Publisher's Site

2011

ACP Journal Club. Review: Evidence for the effectiveness of interventions to prevent foot ulcers in patients with diabetes is limited.

Annals of internal medicine.155(8):JC4-8[DOI] 10.7326/0003-4819-155-8-201110180-02008.[PMID] 22007067.

PubMed·Publisher's Site

2011

Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials.

Journal of diabetes science and technology.5(4):952-65[DOI] .[PMID] 21880239.

70 citations·PubMed·Publisher's Site

2009

ACP Journal Club. Intensive glucose control increased risk for death and severe hypoglycemia in critically ill adults.

Annals of internal medicine.151(4):JC2-5[DOI] .[PMID] 19687479.

PubMed·Publisher's Site

2009

ACP Journal Club. Review: Intensive insulin therapy increases risk for hypoglycemia but not mortality in critically ill adults.

Annals of internal medicine.151(4):JC2-4, JC2[DOI] .[PMID] 19687478.

2 citations·PubMed·Publisher's Site

2009

Glycemic control in the medical intensive care unit.

Journal of diabetes science and technology.3(6):1330-41[DOI] .[PMID] 20144387.

19 citations·PubMed·Publisher's Site

2009

In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status.

Evidence-based medicine.14(6):177-[DOI] 10.1136/ebm.14.6.177.[PMID] 19949179.

PubMed·Publisher's Site

2009

Incretins in the ICU: is insulin on its way out?

Critical care (London, England).13(4):161-[DOI] 10.1186/cc7913.[PMID] 19591659.

6 citations·PubMed·Publisher's Site

2008

Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta-analysis of randomized trials.7.

Mayo Clinic proceedings.83(4):418-30[DOI] .[PMID] 18380987.

55 citations·PubMed·Publisher's Site

2008

Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials.

Clinical endocrinology.69(2):244-52[DOI] 10.1111/j.1365-2265.2008.03179.x.[PMID] 18194488.

8 citations·PubMed·Publisher's Site

2008

Patient-important outcomes in registered diabetes trials.

JAMA.299(21):2543-9[DOI] 10.1001/jama.299.21.2543.[PMID] 18523223.

172 citations·PubMed·Publisher's Site

2007

Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery.

American journal of clinical pathology.127(6):919-26[DOI] .[PMID] 17509989.

66 citations·PubMed·Publisher's Site

2007

Endocrinopathy in POEMS syndrome: the Mayo Clinic experience.

Mayo Clinic proceedings.82(7):836-42[DOI] .[PMID] 17605964.

63 citations·PubMed·Publisher's Site

2007

Glycemic durability of monotherapy for diabetes.

The New England journal of medicine.356(13):1379-80; author reply 1380[DOI] .[PMID] 17402163.

1 citations·PubMed·Publisher's Site

2007

Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.